CD4 Lymphocyte Count
"CD4 Lymphocyte Count" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
Descriptor ID |
D018791
|
MeSH Number(s) |
E01.370.225.500.195.107.595.500.150 E01.370.225.625.107.595.500.150 E05.200.500.195.107.595.500.150 E05.200.625.107.595.500.150 E05.242.195.107.595.500.150 G04.170.107.595.500.150 G09.188.105.595.500.150
|
Concept/Terms |
CD4 Lymphocyte Count- CD4 Lymphocyte Count
- Lymphocyte Count, CD4
- CD4 Lymphocyte Counts
- Lymphocyte Counts, CD4
- CD4 Counts
- CD4 Count
- CD4 Cell Counts
- CD4 Cell Count
- CD4+ Cell Counts
- CD4+ Cell Count
- CD4+ Counts
- CD4+ Count
- T4 Lymphocyte Count
- Count, T4 Lymphocyte
- Counts, T4 Lymphocyte
- Lymphocyte Count, T4
- Lymphocyte Counts, T4
- T4 Lymphocyte Counts
|
Below are MeSH descriptors whose meaning is more general than "CD4 Lymphocyte Count".
Below are MeSH descriptors whose meaning is more specific than "CD4 Lymphocyte Count".
This graph shows the total number of publications written about "CD4 Lymphocyte Count" by people in UAMS Profiles by year, and whether "CD4 Lymphocyte Count" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 0 | 1 | 1 | 2016 | 0 | 4 | 4 | 2015 | 0 | 2 | 2 | 2014 | 0 | 4 | 4 | 2013 | 0 | 5 | 5 | 2012 | 0 | 2 | 2 | 2011 | 1 | 5 | 6 | 2010 | 0 | 3 | 3 | 2009 | 0 | 2 | 2 | 2008 | 1 | 8 | 9 | 2007 | 1 | 3 | 4 | 2006 | 1 | 3 | 4 | 2005 | 1 | 5 | 6 | 2004 | 0 | 2 | 2 | 2003 | 0 | 8 | 8 | 2002 | 1 | 7 | 8 | 2001 | 1 | 5 | 6 | 2000 | 0 | 7 | 7 | 1999 | 0 | 6 | 6 | 1998 | 0 | 9 | 9 | 1997 | 2 | 3 | 5 | 1996 | 0 | 3 | 3 | 1995 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "CD4 Lymphocyte Count" by people in Profiles over the past ten years.
-
Bourgi K, Jenkins CA, Rebeiro PF, Palella F, Moore RD, Altoff KN, Gill J, Rabkin CS, Gange SJ, Horberg MA, Margolick J, Li J, Wong C, Willig A, Lima VD, Crane H, Thorne J, Silverberg M, Kirk G, Mathews WC, Sterling TR, Lake J, Koethe JR. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020 04; 23(4):e25484.
-
Erlandson KM, Zhang L, Lake JE, Schrack J, Althoff K, Sharma A, Tien PC, Margolick JB, Jacobson LP, Brown TT. Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women. Medicine (Baltimore). 2016 Nov; 95(46):e5399.
-
Wada NI, Bream JH, Martínez-Maza O, Macatangay B, Galvin SR, Margolick JB, Jacobson LP. Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study. Clin Infect Dis. 2016 10 01; 63(7):984-990.
-
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses. 2016 08; 32(8):756-62.
-
Lam JO, Bream JH, Sugar EA, Coles CL, Weber KM, Burk RD, Wiley DJ, Cranston RD, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Guo Y, Xiao W, Gillison ML, D'Souza G. Association of serum cytokines with oral HPV clearance. Cytokine. 2016 07; 83:85-91.
-
Margolick JB, Apuzzo L, Singer J, Wong H, Lee T, Gallant JE, El-Helou P, Loutfy MR, Rachlis A, Fraser C, Kasper K, Tremblay C, Tossonian H, Conway B. A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection. PLoS One. 2015; 10(11):e0143259.
-
Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martínez-Maza O, Bream JH. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015 Feb 20; 29(4):463-71.
-
McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, Doherty B, Klausner JD. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Clin Infect Dis. 2015 Mar 15; 60(6):959-65.
-
Barta SK, Xue X, Wang D, Lee JY, Kaplan LD, Ribera JM, Oriol A, Spina M, Tirelli U, Boue F, Wilson WH, Wyen C, Dunleavy K, Noy A, Sparano JA. A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica. 2014 Nov; 99(11):1731-7.
-
McKenney J, Smith RM, Chiller TM, Detels R, French A, Margolick J, Klausner JD. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012. MMWR Morb Mortal Wkly Rep. 2014 Jul 11; 63(27):585-7.
-
Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS. 2014 May 15; 28(8):1227-32.
-
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013; 8(12):e82772.
-
Shen C, Gupta P, Xu X, Sanyal A, Rinaldo C, Seaberg E, Margolick JB, Martinez-Maza O, Chen Y. Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects. Virology. 2014 Jan 20; 449:339-49.
-
Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry MJ, Jay N, Aboulafia DM, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine. HIV Clin Trials. 2013 Mar-Apr; 14(2):75-9.
-
Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, Da Costa M, Panther L, Aboulafia D, Palefsky JM. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS. 2013 Feb 20; 27(4):545-51.
-
Muzaffar J, Usmani S, Abdallah AO, Anaissie E, Cottler-Fox M, Restrepo A. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):171-4.
-
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. HIV incidence determination in the United States: a multiassay approach. J Infect Dis. 2013 Jan 15; 207(2):232-9.
-
Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, Reid EG, Aboulafia DM, Ratner L, Mitsuyasu R, Cooley T, Henry DH, Barr P, Noy A. Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma. 2012 Dec; 53(12):2383-9.
-
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses. 2012 Aug; 28(8):816-22.
-
Pathak V, Rendon IS, Atrash S, Gagadam VP, Bhunia K, Mallampalli SP, Vegesna V, Dangal MM, Ciubotaru RL. Comparing outcomes of HIV versus non-HIV patients requiring mechanical ventilation. Clin Med Res. 2012 May; 10(2):57-64.
-
Li X, Margolick JB, Jamieson BD, Rinaldo CR, Phair JP, Jacobson LP. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy. . 2011 Aug 15; 57(5):421-8.
-
Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, Margolick JB. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011 Sep; 66(9):1030-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|